176506-72-2

Upstream product

• 176506-71-1 Benzoic acid (1S,2R,3R,4S,5R,6S)-2-benzyloxy-6-benzyloxymethoxy-5-fluoro-3,4-bis-(4-methoxy-benzyloxy)-cyclohexyl ester 
• 176506-70-0 (1S,2R,3S,4R,5S,6S)-3-Benzyloxy-6-fluoro-4,5-bis-(4-methoxy-benzyloxy)-cyclohexane-1,2-diol 
• 120444-24-8 D-3-deoxy-3-fluoro-myo-inositol 
• 129365-59-9 (3aS,4S,4aR,7aS,8S,8aS)-4-Benzyloxy-8-fluoro-2,2,6,6-tetramethyl-hexahydro-benzo[1,2-d;4,5-d']bis[1,3]dioxole 
• 129365-60-2 (3aS,4R,5S,6S,7R,7aS)-4-Benzyloxy-7-fluoro-2,2-dimethyl-hexahydro-benzo[1,3]dioxole-5,6-diol 
• 129444-05-9 (3aS,4S,4aR,7aS,8S,8aS)-8-Fluoro-2,2,6,6-tetramethyl-hexahydro-benzo[1,2-d;4,5-d']bis[1,3]dioxol-4-ol 
• 990-91-0 dibenzyl [[bis(benzyloxy)phosphoryl]oxy]phosphonate 

Relevant academic research and scientific papers

Synthesis of novel metabolically stable analogues of D-myo-inositol 1,4,5-trisphosphate

Starting from L-quebrachitol, syntheses and biological activities of three novel analogues of the cellular second messenger D-myo-inositol 1,4,5-trisphosphate (IP3), 3-deoxy-3-fluoro-D-myo-inositol 1,4-bisphosphate 5-phosphorothioate (1a), 3-deoxy-3-fluoro-D-myo-inositol 1,5-bisphosphate 4-phosphorothioate (1b), and 3-deoxy-3-fluoro-D-myo-inositol 1-phosphate 4,5-bisphosphorothioate (1c) are described.